Exploring the Potential of the Corpus Callosum Area as a Predictive Marker for Impaired Information Processing in Multiple Sclerosis

Siponimod and Cognition in Secondary Progressive Multiple Sclerosis

(2021) Ralph H.B. Benedict et al.   NEUROLOGY

Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis

(2021) Yang Tao et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing‐remitting multiple sclerosis

(2021) Dawn W. Langdon et al.   EUROPEAN JOURNAL OF NEUROLOGY

Measurements of the corpus callosum index and fractional anisotropy of the corpus callosum and their cutoff values are useful to assess global brain volume loss in multiple sclerosis

(2020) Juichi Fujimori et al.   Multiple Sclerosis and Related Disorders

Silent Progression in Disease Activity-Free Relapsing Multiple Sclerosis

(2019) et al.   ANNALS OF NEUROLOGY

Cognition in multiple sclerosis

(2018) James F. Sumowski et al.   NEUROLOGY

Progressive multiple sclerosis, cognitive function, and quality of life

(2018) Helene Højsgaard Chow et al.   Brain and Behavior

Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis

(2018) Chunjie Guo et al.   EUROPEAN RADIOLOGY

Measuring functional connectivity in stroke: Approaches and considerations

(2017) Joshua S Siegel et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index

(2015) Tobias Granberg et al.   JOURNAL OF NEUROIMAGING

Association of cognitive impairment and lesion volumes in multiple sclerosis – A MRI study

(2014) Murat Yildiz et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study

(2014) Tobias Granberg et al.   Multiple Sclerosis Journal

Magnetic resonance monitoring of lesion evolution in multiple sclerosis

(2013) Àlex Rovira et al.   Therapeutic Advances in Neurological Disorders

Brief International Cognitive Assessment for MS (BICAMS): international standards for validation

(2012) Ralph HB Benedict et al.   BMC Neurology

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis

(2012) S. Mesaros et al.   NEUROLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS

(2011) Bianca Weinstock-Guttman et al.   JOURNAL OF NEUROLOGY

Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis

(2011) Sonia Batista et al.   JOURNAL OF NEUROLOGY

Risk factors for and management of cognitive dysfunction in multiple sclerosis

(2011) Ralph H. B. Benedict et al.   Nature Reviews Neurology

Corpus callosum index and long-term disability in multiple sclerosis patients

(2010) Özgür Yaldizli et al.   JOURNAL OF NEUROLOGY

Reliability, practice effects, and change indices for Rao’s brief repeatable battery

(2010) Emilio Portaccio et al.   Multiple Sclerosis Journal

Multiple Sclerosis With Predominant, Severe Cognitive Impairment

(2009) Nathan P. Staff et al.   ARCHIVES OF NEUROLOGY

Multiple Sclerosis: An Immune or Neurodegenerative Disorder?

(2008) Bruce D. Trapp et al.   Annual Review of Neuroscience

Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis

(2008) R. A. Dineen et al.   BRAIN